What are Monoclonal Antibodies (mAb)
- Not a new technology.
- They are artificial antibodies created by pharmaceutical companies.
- They work like natural antibodies.
- They target specific contagions such as the SARS-CoV-2 spike protein.
- Evidence suggests that mAb treatment can reduce the amount of the SARS-CoV-2 virus (the viral load) in a person’s system. Having a lower viral load means you may have milder symptoms thereby decreasing the likelihood of you needing to stay in the hospital.
- mAb treatment may help people who:
- Have a positive COVID-19 test, and had symptoms for 10 days or less.
- Are at high risk of getting more serious symptoms.
Reference: Monoclonal Antibodies vs. Vaccines vs. COVID-19: What to Know